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Purpose	Women with breast cancer have complex and unique gynecologic needs that are challenging to
effectively and comprehensively meet in a traditional gynecology visit format. Group medical visits are
an effective and well-received model of care in other disease settings and can provide comprehensive
health education as an adjunct to one-on-one evaluation and treatment. There are limited data
regarding the use of this type of health care delivery in providing gynecology-focused care to women
affected by breast cancer.
Methods	A group medical visit model was created for gynecology providers to see new breast cancer patient
consults. From May 2012 to February 2014, 148 patients (3–6 per group) participated in a 1-hour
informational session followed by a 15- to 30-minute individual visit with a physician that included
history, physical examination and evaluation. We surveyed 101 women who attended these visits to
evaluate a group model for providing gynecologic care and educational support to women with breast
cancer.
Results 	
Of those who responded to the survey question, 100% agreed or somewhat agreed that their
expectations for an initial intake visit were met during the group visit; 81% agreed or somewhat agreed
that they felt a group visit was preferable to an individual introductory visit. More than 95% agreed or
somewhat agreed that the information was understandable and their questions were answered during
the visit. Only 5 respondents expressed dissatisfaction with the additional time commitment for this
type of visit.
Conclusions	The majority of women surveyed expressed satisfaction with their experience with a group visit format.
The women who participated preferred this format compared to an individual intake appointment when
establishing gynecology care after breast cancer diagnosis/treatment, regardless of age, menopausal
status, cancer stage or hormone receptor status. While further studies are warranted to directly
compare and further assess satisfaction and efficacy, gynecologists may consider using a group model
to provide comprehensive education and care to this patient population. (J Patient Cent Res Rev.
2017;4:18-23.)
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Breast cancer treatment has significant gynecologic
implications. Fertility preservation, safety of pregnancy
posttreatment, role of ovarian suppression, sexual
dysfunction and safe management of menopausal
symptoms induced by chemotherapy or hormonal
therapies are common issues that affect many breast
cancer survivors. It is difficult to address some of these
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in a traditional gynecologic visit. Gynecologic care for
a woman affected by breast cancer requires assessment
and management of many complex medical issues and
requires extensive counseling and evaluation.
A literature search revealed a dearth of studies focused
on how to best provide gynecologic care to patients with
breast cancer. As detailed in the federal report “From
Cancer Patient to Cancer Survivor: Lost in Translation,”
evidence is needed for all aspects of survivorship
care.1 Providing care that is satisfactory to the patient
ultimately affects the patient’s quality of life.2

Original Research

The challenges of providing care to women affected
by breast cancer echo the challenges of caring
for patients with chronic conditions that require
comprehensive education and support in a system
with finite resources. Group medical visits were
developed to increase face time with health care
providers and information given to patients.3 The
group medical visit is a model of health care delivery
that brings patients with similar health issues together
in a group format for education and support led by a
health professional. Individual medical assessments
are conducted, but the educational piece is provided
in this group format.
Group medical visits for prenatal care are well
established in the field of obstetrics.4-6 This visit format
has been studied and used to provide care in many other
patient populations, including breast cancer survivors
and women with BRCA mutations.2,7,8 However,
these studies focus on group care as it relates to the
treatment of breast cancer and have not addressed
specific women’s health and gynecologic needs.
Group visits have been shown to improve quality of
care by improving patient and provider satisfaction
in managing chronic conditions such as diabetes and
chronic pelvic pain.4,9,10
The acceptability of the group medical visit model to
provide education regarding the gynecologic effects of
breast cancer treatment has not been explored, though a
similar model focused only on breast cancer treatment
yielded positive results.8 Inspired by the large number
of referrals of women with breast cancer for quality-oflife issues,11 we investigated group visits as a means of
providing education regarding the gynecologic effects
of breast cancer treatments.

METHODS

We surveyed women who sought gynecologic care related
to their breast cancer diagnosis and treatment at a single
tertiary care institution. At the initiation of this study, the
authors developed a group-based model to see new consult
patients. The intention was to increase capacity as well as
promote an alternative model for providing educational
services to women with breast cancer. Participants were
recruited from all patients establishing gynecologic care
after breast cancer, and informed consent was obtained.
The study was approved by the university’s institutional
review board with jurisdiction.
Original Research

Group medical visits involved 3–6 patients. On
presentation women received educational handouts
regarding gynecologic and quality-of-life issues common
to patients with breast cancer. Within the group setting
a gynecologist spoke and answered questions for 60
minutes about gynecologic concerns related to a breast
cancer diagnosis, including the role of hormonal therapies
and its side effects, the role of ovarian suppression and
when to consider oophorectomy, fertility preservation,
safety of pregnancy after breast cancer, management of
sexual dysfunction and safe treatment of menopausal
side effects induced by chemotherapy or drugs like
selective estrogen receptor modulators and aromatase
inhibitors. There was a focus on normalizing sexual
health problems and discussion of possible solutions.
After an hour of group visit, patients were directed to
exam rooms for individual 15- to 30-minute visits with
the provider that included physical examination and
time for personal questions and care planning.
All patients who participated in the group visits were
approached for enrollment in this study. Those who
expressed interest received a written consent form and a
semi-structured survey about their experience. The surveys
were generated by the research team and were based on
patient satisfaction surveys and assessments of health
care delivery. They included Likert scale and open-ended
questions (Online Appendix 1). In addition to age and
menopausal status, patients were asked about their disease
characteristics, treatment, knowledge about their condition
and satisfaction with the group format as it pertained to
specific elements of the visit. The surveys were confidential
in that no identifying information was collected.
Statistical analysis was performed on survey
data collected to look for differences related to
demographics. Significance was set at P<0.05. For
the Likert scale questions, chi-squared was chosen
to look for differences in response distribution based
on selected characteristics. For binomial survey
outcomes, Fisher’s exact test was used. Data were
analyzed via Stata 12.0 (StataCorp LP, College Station,
TX). No power calculation was set for this part of the
study because there was no comparison group and
the study was designed to address the feasibility and
acceptability of a new model of health care delivery.
All written survey responses were extracted from
surveys to be coded. Qualitative data were coded
www.aurora.org/jpcrr
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independently by two researchers. For simplicity, data
were coded into positive and negative responses to
the group visits. Disagreements between coders were
resolved by third party. After completion of coding,
coauthors identified representative statements to help
better elucidate the identified themes.

RESULTS

A total of 148 women attended group medical visits
from May 2012 to February 2014, and 101 (68.2%)
of these women filled out study consent and the semistructured survey. Not all women provided answers to
all questions in the survey, which accounts for some
discrepancies in the number of responses per question.
Age range, breast cancer stage, tumor hormone
receptor status and menopausal status of the 101
survey respondents are presented in Table 1. More
than half (53%) of the women were less than 51 years
old; 59 women (78%) had stage I or II breast cancer
at the time of the visit, whereas 12 (16%) had laterstage disease. Nearly half (47%) of respondents were
premenopausal, while 36% were in natural menopause
and 17% were treatment-induced postmenopausal.
Of those who selected a response, 82% had hormone
receptor-positive breast cancer and 13 (17%) had
hormone receptor-negative breast cancer.
Question-specific responses by all women who
participated are found in Table 2. All but one survey
question, which asked if the study participant would be
interested in a group format for follow-up visits, had a
response rate of at least 85%. Only 47 women (47%)
answered that question; of these, 77% (n=36) indicated
they agreed or somewhat agreed that they would be
interested. All respondents agreed or somewhat agreed
that their expectations were met during the visit, 81%
(n=72) agreed or somewhat agreed that they felt a
group visit was preferable to individual intake, and 79%
(n=73) agreed or somewhat agreed that they preferred to
be in a group of survivors/at-risk women. Of those who
answered the question, 99% (n=90) agreed or somewhat
agreed that the information was understandable and
97% (n=89) agreed or somewhat agreed that they had
their questions answered.
There were no significant differences in response
distribution when answers were stratified by age or
hormone receptor status. Patients with early-stage
20
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Table 1. Characteristics of Group Medical Visit Participants
Characteristic

N=101*

Age
Total responses to age
Age 35–51 years
Age ≥ 51 years
Age < 35 years

83 (100%)
42 (51%)
39 (47%)
2 (2%)

Stage of breast cancer
Total responses
Early stage (I/II)
Late stage (III/IV)
Other/unsure

76 (100%)
59 (78%)
12 (16%)
5 (7%)

Menopausal status
Total responses
Premenopausal
Postmenopausal

81 (100%)
38 (47%)
29 (36%)

Treatment-induced menopause

14 (17%)

Hormone receptor status
Total responses
Hormone receptor-positive
Hormone receptor-negative
Unsure

78 (100%)
64 (82%)
13 (17%)
1 (1%)

*Not all participants answered all questions.

disease were found to have a more neutral attitude
to the visits compared to patients with later-stage
disease (P=0.02). Eight (33%) postmenopausal women
disagreed when asked if they would be interested in
a group format for a follow-up visit. While this was
higher than those who were premenopausal, it did not
meet statistical significance (P=0.07).
In terms of qualitative data, 119 written responses or
comments were found among all surveys and were
coded as positive, neutral or negative. Also coded were
responses that expressed shyness related to the group
format, concerns about time commitment and additional
questions. Each comment received a single code. In all,
54 comments were coded as expressing positive feelings
toward the group visit format compared to an individual
appointment, 18 expressed neutral or mixed feelings,
and 8 reported negative feelings toward the group format.
Three people expressed shyness about the group format.
Five women expressed concerns about time commitment.

DISCUSSION

Group medical visits are an innovative care model that
has previously been shown to improve quality of health
care. It has successfully increased patient and provider
Original Research

Table 2. Survey Responses by All Participants (N=101)
Disagree /
somewhat disagree*
n (%)

Neutral
n (%)

Somewhat
agree / agree*
n (%)

All
responses
n (%)

0

0

91 (100%)

91 (100%)

2. Felt group visit preferable to individual intake

4 (4%)

13 (15%)

72 (81%)

89 (100%)

3. Prefer to be in a group of survivors/at-risk women

3 (3%)

16 (17%)

73 (79%)

92 (100%)

0

1 (1%)

90 (99%)

91 (100%)

Question
1. Felt expectations were met

4. Information was understandable
5. My questions were answered

0

3 (3%)

89 (97%)

92 (100%)

4 (5%)

17 (19%)

67 (76%)

88 (100%)

0

0

91 (100%)

91 (100%)

2 (2%)

5 (5%)

84 (92%)

91 (100%)

3 (3%)

2 (2%)

88 (95%)

93 (100%)

11 (23%)

n/a

36 (77%)

47 (100%)

6. Learned about resources for a healthier lifestyle
7. Understand the gynecologic effects of my
medical treatment
8. Know some of the remedies for side effects of
my treatment
9. Understand the role of removing ovaries
10. Interested in a group format for follow-up visits

Not all 101 participants answered all questions. *Two categories combined from the questionnaire.

satisfaction and objectively improved health care
outcomes in primary prevention and chronic condition
management.6,7,9 Our study suggests that new patients
were satisfied with group visits and would prefer such
a model compared to a one-on-one consultation when
establishing gynecologic care tailored for women
affected by breast cancer.
There is a need to provide comprehensive gynecologic
care to the expanding population of women with breast
cancer.12,13 Group visits have the potential to provide
comprehensive care to these patients in a novel setting.
Most women responding to our study survey felt that
their expectations were met by a group visit and stated
a preference for the group format for an introductory
visit regardless of their age, stage of disease, hormone
receptor status or menopausal status.
Despite the complex needs of patients who have been
diagnosed with breast cancer, information delivery in
this setting was perceived as a positive experience. At
least 90% of women felt they had better knowledge
of how treatment affected their gynecologic health and
that they had a better understanding of the side effects
from these treatments.
The limited differences found among group demographics
suggest that the group visit format can provide effective
care to women despite differences in age, stage of
disease, tumor hormonal status or menopausal status. As
Original Research

more women had hormone-sensitive disease, questions
from patients in the group may have been more tailored
toward hormone-sensitive disease treatments, and thus a
woman with hormone-negative breast cancer could feel
those discussions were not applicable to her personal
care. However, women with hormone receptor-negative
tumors provided predominantly positive feedback about
their group experience. Similarly, women with latestage disease stated preferences for the group as much as
women with early-stage disease despite likely differences
in previous knowledge, experiences and emotional needs.
Women with stage 0 disease were not studied.
More research needs to be conducted to determine what
aspects of the group setting were most appealing to
women and how to improve patient satisfaction for those
less agreeable to the group setting. Further dividing
women by their tumor’s hormone status, menopause
status and stage of disease is one potential solution to
deliver more targeted information and improve patient
receptivity. It is important to point out that our findings
may not apply to all women referred for gynecologic
care after breast cancer. For instance, 5 women in our
study commented on their concerns about the time
commitment. However, most of the women in our study
did not indicate strong feelings about the time spent.
A majority of women not only stated a preference for the
group visit format, but also expressed that their medical
questions were answered and that the information
www.aurora.org/jpcrr
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provided was understandable. While this study suggests
patients are satisfied with and receive comprehensive
information and answers from this appointment format,
it is not known whether an individual appointment
offers the same level of education, information and
support. In comparison to nearly 80% of quantitative
responses indicating preference of group visits,
qualitative data was deemed positive in 50% of
responses. It is possible this lower rate was the result
of those who had positive experiences feeling satisfied
with communicating via the quantitative responses and
who therefore lacked incentive to take the additional
time to write qualitative comments.
There are elements of the group format that may uniquely
contribute to care in ways an individual appointment
with a gynecologist does not. A group visit is potentially
a powerful format to destigmatize and support women
affected by breast cancer who have concerns related
to sexual function, sexual pain and personal identity.
Women may be experiencing symptoms they would
not voice in an individual visit. A good example of this
relates to sexual health. One retrospective study found
that only 7% of women sought care for sexual health
concerns but 40% of women expressed interest in
receiving such care.11 Within a group setting women can
benefit from the questions of others who share similar
symptoms that can be difficult to discuss with individual
providers but significantly impact quality of life.
While the group model can provide unique support,
it is important to recognize that patients may share a
disease but still have diverse needs. Therefore, it can
be challenging to tailor group counseling to meet those
needs. The individual counseling and examination after
the group session allows structured time to address
concerns and objective findings individually. With the
group counseling followed by individual consultation
format, we observed few differences in satisfaction
and preference for group visits by age, stage of disease,
menopause status and tumor hormone receptivity. It
may be beneficial to group similar patients (e.g. latestage, hormone receptor-negative) to further tailor
patient education and improve satisfaction.
Limitations
Only 47% of women surveyed answered the question
regarding interest in a group format for follow-up visits.

22

JPCRR • Volume 4, Issue 1 • Winter 2017

Of those who responded, 36 (76%) stated interest. It
is unclear whether this lower response rate suggests less
certainty about preference for future visits and is one of
the limitations of our study. It could be due to the fact
that patients were presenting for initial consultation to
a university referral center with the plan to return to a
primary gynecologist, or it could be that patients received
enough information at the initial visit, or it could be a
variety of other reasons not illuminated by our study.
Another limitation is we did not randomize patients
to individual or group visit –– we only surveyed
participants in the group –– and therefore cannot
compare group visits to individual visits. Not all
participants answered all of the questions on the
survey. It is unclear why some questions were skipped
by respondents, and no patterns were identified.
Item nonresponse is a well-known entity in survey
research, as some questions may not apply to specific
respondents or they choose not to answer for other
reasons. Additionally, the group was directed by
one provider; therefore much of the satisfaction or
understanding may be due to the provider’s ability to
disseminate information regardless of setting.
While almost 70% of women involved in the program
chose to participate in the survey, we did not obtain
complete demographic data for all participants as not
all women answered every question. There may be
differences in experience between those who completed
surveys and those who did not. There may be differences
between those who chose to omit an answer to a specific
question and those who did not. Demographic data
such as ethnicity and educational background were not
collected and could potentially impact receptivity to
group visits. We did not compare demographics of those
presenting for group visits to those otherwise seen for
care at our medical center. Further studies comparing
patient experience at group and individual visits to
determine which setting is preferred, and which provided
more effective education and support, are needed.

CONCLUSIONS

Women with breast cancer comprise a particularly
high-need population because of their increased cancer
risk, complex therapies and interconnection with
multiple specialists including gynecologists. Assessing
the model of care for women affected by breast cancer

Original Research

is necessary to improve health care delivery efficiency
and to improve quality of life and treatment outcomes
for this population. The traditional new individual
patient appointment at a gynecology practice is often
not designed for the complex level of care required to
address the multifaceted needs of patients with breast
cancer. We found that the group medical visit was a
well-received means of providing care in this setting.
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There are challenges to designing and implementing
novel appointment formats like group visits into a
practice. We hope this study illuminates their potential
efficacy in providing tailored care to a complex
population and describes a model that was used to
welcome as many as eight patients an afternoon into
our clinical practice. As with other chronic medical
conditions, group visits for gynecologic care in
women with breast cancer were found to be potentially
beneficial for health care delivery, with high provider
and patient satisfaction. More research is needed to
investigate strategies for improved efficacy, such as
creation of subgroups and follow-up groups.
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Patient-Friendly Recap
• Group medical visits have been combined
with one-on-one clinical evaluations to offer
health education and patient-centered care for a
handful of chronic diseases.
• Women affected by breast cancer have special
needs for their gynecologic care.
• The authors evaluated a program in which
small groups of women with breast cancer
participated in a 1-hour informational session
on gynecologic care followed by a 15- to
30-minute individual visit with a gynecologist.
• A survey of patient participants revealed that
the group visit met patients’ expectations,
and that most women (81%) found the format
preferable to an individual visit only.
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